High-Dose Vitamin C for Cancer Therapy

Area of Science:

• Oncology
• Nutritional Biochemistry
• Pharmacology

Background:

• Vitamin C (Vit-C) has shown contradictory results as an anti-cancer therapy.
• Recent preclinical data suggest high-dose Vit-C may manage various tumor types.
• Vit-C's pharmacological actions can disrupt cancer cell growth and development.

Purpose of the Study:

• To discuss the anti-cancer functions of Vitamin C.
• To explore Vit-C's potential as an epigenetic regulator and immunotherapy enhancer.
• To review reactive oxygen species (ROS) scavenging systems in relation to high-dose Vit-C toxicity and cancer inhibition.

Main Methods:

• Review of recent insights into Vit-C's physiological characteristics and pharmacokinetics.
• Analysis of preclinical reports on Vit-C's anti-cancer effects.
• Discussion of current ROS scavenging systems and their influence on high-dose Vit-C therapy.

Main Results:

• High-dose Vitamin C demonstrates potential in targeting cancer cell proliferation and development.
• Vit-C may act as an epigenetic regulator and enhance immunotherapy responses.
• Understanding ROS scavenging is crucial for managing high-dose Vit-C toxicity in cancer treatment.

Conclusions:

• While promising, the anti-cancer mechanisms of high-dose Vit-C require validation through robust clinical trials.
• Future research should identify optimal cancer patient populations for Vit-C therapy.
• Developing combination strategies integrating Vit-C with concurrent cancer treatments is essential.